Anhui Palo Alto Pharmaceuticals, Inc.

This early-stage study tested a new asthma inhaler drug (PA9159) in 40 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it. Participants received single or repeated doses of the inhaler. Since it was a safety study in healthy peop…

This early-stage study tested a new corticosteroid nasal spray called PA9159 in 36 healthy Chinese adults. The goal was to see if it is safe and how the body processes it, not to treat any condition. Participants received either the spray or a placebo for up to 7 days, and resear…